###begin article-title 0
Switching-On Survival and Repair Response Programs in Islet Transplants by Bone Marrow-Derived Vasculogenic Cells
###end article-title 0
###begin p 1
###xml 35 52 35 52 <email xmlns:xlink="http://www.w3.org/1999/xlink">crisa@scripps.edu</email>
Corresponding author: Laura Crisa, crisa@scripps.edu
###end p 1
###begin p 2
Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. See  for details.
###end p 2
###begin p 3
###xml 0 10 0 10 <bold xmlns:xlink="http://www.w3.org/1999/xlink">OBJECTIVE&#8212;</bold>
OBJECTIVE-Vascular progenitors of bone marrow origin participate to neovascularization at sites of wound healing and transplantation. We hypothesized that the biological purpose of this bone marrow-derived vascular component is to contribute angiogenic and survival functions distinct from those provided by the local tissue-derived vasculature.
###end p 3
###begin p 4
###xml 0 40 0 40 <bold xmlns:xlink="http://www.w3.org/1999/xlink">RESEARCH DESIGN AND METHODS AND RESULTS&#8212;</bold>
###xml 212 215 212 215 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/&#8722;</sup>
###xml 218 221 218 221 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 222 226 <span type="species:ncbi:10090">mice</span>
RESEARCH DESIGN AND METHODS AND RESULTS-To address this hypothesis, we investigated the functional impact of bone marrow-derived vascular cells on pancreatic islets engraftment using bone marrow-reconstituted Id1+/-Id3-/- mice, a model of bone marrow-derived vasculogenesis. We show that, in this model, bone marrow-derived vasculogenic cells primarily contribute to the formation of new blood vessels within islet transplants. In contrast, graft revascularization in a wild-type background occurs by tissue-derived blood vessels only. Using these distinct transplant models in which bone marrow-and tissue-derived vasculature are virtually mutually exclusive, we demonstrate that bone marrow-derived vasculogenic cells exhibit enhanced angiogenic functions and support prompt activation of islets survival pathways, which significantly impact on islets engraftment and function. Moreover, gene profiling of vascular and inflammatory cells of the grafts demonstrate that neovascularization by bone marrow-derived cells is accompanied by the activation of a genetic program uniquely tuned to downregulate harmful inflammatory responses and to promote tissue repair.
###end p 4
###begin p 5
###xml 0 12 0 12 <bold xmlns:xlink="http://www.w3.org/1999/xlink">CONCLUSIONS&#8212;</bold>
CONCLUSIONS-These studies uncover the biological significance of bone marrow-derived vasculogenic cells in the response to injury during transplantation. Enhancing the contribution of bone marrow-derived vasculogenic cells to transplantation sites may help to overcome both limited angiogenic responses of the adult tissue-derived vasculature and untoward effects of inflammation on transplant engraftment.
###end p 5
###begin p 6
Published ahead of print at  on 2 June 2008.
###end p 6
###begin p 7
The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C Section 1734 solely to indicate this fact.
###end p 7
###begin p 8
###xml 152 153 152 153 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r1">1</xref>
###xml 309 310 309 310 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r2">2</xref>
###xml 311 312 311 312 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r9">9</xref>
###xml 479 480 479 480 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r2">2</xref>
###xml 481 482 481 482 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r6">6</xref>
###xml 483 484 483 484 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r9">9</xref>
###xml 485 487 485 487 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r15">15</xref>
###xml 658 659 658 659 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r2">2</xref>
###xml 660 661 660 661 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r7">7</xref>
###xml 662 663 662 663 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r8">8</xref>
Tissue repair after wounding and/or cell transplantation requires the concerted regulation of angiogenic and self-limited local inflammatory responses (1). Several studies have shown that angiogenic responses involve both tissue-derived vascular cells and circulating bone marrow-derived vascular precursors (2-9). The potential of these progenitors to develop into endothelial and/or perivascular cells supporting tumorigenesis and tumor growth has been extensively documented (2-6,9-15). In the context of primary tissues, a much more limited incorporation of these cells into injured blood vessels has been observed, suggesting a role in vascular repair (2,7,8). Whether in this instance the angiogenic response of such bone marrow-derived vascular component is distinct from that supported by preexisting tissue-derived blood vessels and/or contributes a biological advantage is presently unknown. Furthermore, the potential of bone marrow-derived vascular cells to influence local inflammatory responses normally associated with angiogenesis has not been addressed.
###end p 8
###begin p 9
###xml 198 200 198 200 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r16">16</xref>
###xml 201 203 201 203 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r19">19</xref>
###xml 693 696 693 696 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/&#8722;</sup>
###xml 699 702 699 702 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 757 758 757 758 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r9">9</xref>
###xml 759 761 759 761 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r20">20</xref>
###xml 869 871 869 871 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r21">21</xref>
###xml 890 893 890 893 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 896 899 896 899 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 1016 1018 1016 1018 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r20">20</xref>
###xml 1037 1040 1037 1040 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/&#8722;</sup>
###xml 1043 1046 1043 1046 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 1264 1265 1264 1265 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r9">9</xref>
###xml 1335 1338 1335 1338 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/&#8722;</sup>
###xml 1341 1344 1341 1344 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 1410 1411 1410 1411 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r9">9</xref>
###xml 703 708 <span type="species:ncbi:10090">mouse</span>
###xml 909 913 <span type="species:ncbi:10090">mice</span>
###xml 1047 1051 <span type="species:ncbi:10090">mice</span>
###xml 1171 1175 <span type="species:ncbi:10090">mice</span>
###xml 1345 1349 <span type="species:ncbi:10090">mice</span>
Pancreatic islet transplants are highly sensitive to the efficiency of revascularization, because defects of this process result in rapid cell loss and/or altered response of the grafts to glucose (16-19). Thus, islet transplants provide an ideal model to assess the impact of bone marrow-derived vascular cells on both survival and function of a primary tissue. Hence, we hypothesized that bone marrow-derived vasculogenic cells, recruited at sites of pancreatic islet transplantation, contribute engrafting and survival functions distinct from those provided by the endothelium sprouting from the preexisting vasculature. To address this hypothesis, we used the bone marrow-reconstituted Id1+/-Id3-/- mouse, a model of bone marrow-derived vasculogenesis (9,20). Id1 and Id3 transcription factors regulate vascular and neuronal cell differentiation and proliferation (21). Accordingly, Id1-/-Id3-/- knockout mice exhibit severe vascular malformations, including absence of sprouting and branching of blood vessels (20). In contrast, Id1+/-Id3-/- mice, maintaining one functional Id1 allele, display no overt vascular defects. However, preexisting blood vessels in these mice fail to mount an efficient angiogenic response to support tumor transplant engraftment (9). Interestingly, reconstitution of the hemopoietic compartment of Id1+/-Id3-/- mice with wild-type bone marrow rescues tumor revascularization (9). Moreover, in these bone marrow chimeras, >90% of the endothelium forming new blood vessels in the tumor implants is derived from wild-type bone marrow, indicating that neovascularization is sustained almost entirely by bone marrow-derived endothelial precursors.
###end p 9
###begin p 10
###xml 206 210 <span type="species:ncbi:10090">mice</span>
Here, we exploited this model for islet transplantation, and we demonstrate that the majority of new blood vessels formed at the site of islet transplantation in bone marrow-reconstituted Id1/Id3-deficient mice are of bone marrow origin. In contrast, revascularization of islet transplants in bone marrow-reconstituted wild-type recipients occurs predominantly by tissue-derived blood vessels. Using these transplantation models, we provide evidence that tissue- and bone marrow-derived vasculatures are not functionally equivalent, in that development of bone marrow-derived blood vessels is associated with enhanced angiogenesis and with the activation of survival and cellular pathways uniquely skewed toward protective inflammatory responses and tissue repair.
###end p 10
###begin title 11
RESEARCH DESIGN AND METHODS
###end title 11
###begin title 12
Animals and bone marrow reconstitution.
###end title 12
###begin p 13
###xml 3 6 3 6 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/&#8722;</sup>
###xml 9 12 9 12 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/&#8722;</sup>
###xml 114 117 114 117 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/&#8722;</sup>
###xml 120 123 120 123 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 168 170 168 170 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r20">20</xref>
###xml 363 364 363 364 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 450 451 450 451 <sup xmlns:xlink="http://www.w3.org/1999/xlink">6</sup>
###xml 510 513 510 513 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/&#8722;</sup>
###xml 516 519 516 519 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 675 676 675 676 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 694 695 691 692 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 732 733 726 727 <sc xmlns:xlink="http://www.w3.org/1999/xlink">d</sc>
###xml 27 31 <span type="species:ncbi:10090">mice</span>
###xml 124 128 <span type="species:ncbi:10090">mice</span>
###xml 248 252 <span type="species:ncbi:10090">mice</span>
###xml 520 524 <span type="species:ncbi:10090">mice</span>
Id1+/-Id3+/- and wild-type mice were bred at The Scripps Research Institute (TSRI) pathogen-free facility, and Id1+/-Id3-/- mice were screened as described previously (20). C56BL/6-TgN(ACTBEGFP)1Osb, ROSA26 (The Jackson Laboratories), or wild-type mice were used as bone marrow donors. Bone marrow cells were flushed from femurs with RPMI-10% FCS, depleted of CD3+ T-cell using magnetic beads (Miltenyi Biotech), and injected intravenously (5-10 x 106) in 6- to 8-week-old lethally irradiated wild-type and Id1+/-Id3-/- mice (1,200 rads). After 6 weeks, bone marrow reconstitution was assessed by flow cytometry of peripheral blood to identify green fluorescent protein (GFP)+ cells or beta-gal+ cells stained with fluorescein-beta-d-galactopyranosyde (Molecular Probes).
###end p 13
###begin title 14
Islet isolation and transplantation.
###end title 14
###begin p 15
###xml 310 312 310 312 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r22">22</xref>
###xml 215 219 <span type="species:ncbi:10090">mice</span>
###xml 412 416 <span type="species:ncbi:10090">mice</span>
###xml 526 530 <span type="species:ncbi:10090">mice</span>
Islets were isolated by intraductal injection of 0.5 mg/ml liberase and purified on a Ficoll gradient. Islets were cultured overnight in RPMI-10% FCS, handpicked, and transplanted under the kidney capsule. Diabetic mice were generated by intraperitoneal injection of a single dose of 200 mg/kg streptozotocin (22) and transplanted with islets 1 week later. Upon ensuing of frank hyperglycemia (i.e., 200 mg/dl), mice were injected subcutaneously with insulin (Humulin L; Lilly) up to 3 days after transplant. In normoglycemic mice, the function of the graft was verified by the return to hyperglycemia on removal of the graft.
###end p 15
###begin title 16
Histology.
###end title 16
###begin p 17
###xml 234 235 233 234 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r8">8</xref>
###xml 38 42 <span type="species:ncbi:10090">mice</span>
To identify functional blood vessels, mice were injected intravenously with 200 mug fluorescein isothiocyanate-labeled isolectin-B4 (FITC-ISB4) (Molecular Probes) before euthanasia. Tissues were immunostained as described previously (8) using the antibodies listed in the online appendix available at . Apoptotic cells were detected by transferase-mediated dUTP nick-end labeling (TUNEL) using a digoxygenin-labeling kit (Chemicon). Sections were visualized at a Zeiss Axiovert microscope equipped with a scanning laser confocal attachment (Radiance-2000; Bio-Rad) or at a NIKON Eclipse-800 microscope, equipped with a Spot II CCD camera. Morphometric analysis were performed on approximately20-30 sections per graft collected at 100-mum intervals until exhaustion of the grafts using the Spot Advanced and ImageProPlus software.
###end p 17
###begin title 18
Cell separation and flow cytometry.
###end title 18
###begin p 19
###xml 404 405 397 398 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 695 696 688 689 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 705 706 698 699 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 751 752 744 745 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
After in vivo injection of FITC-ISB4, grafts were microdissected and dissociated at 37degreesC in Hanks' balanced salt solution, 0.5 mg/ml liberase, and 50 mug/ml DNase I followed by nonenzymatic dissociation medium (Sigma). Cells were then incubated with primary and secondary antibodies as detailed in the online appendix. For cell isolation, single cells dissociated from biotin-ISB4-perfused grafts (n = 5) were labeled with primary antibodies followed by R-phycoeritrin--conjugated secondary reagents and anti-phycoeritrin microbeads (Miltenyi Biotech) as detailed in the online appendix. Cells were positively selected on magnetic columns and analyzed at a FACScan (Becton Dickinson). CD31+ and F480+ cells were >90% pure, whereas purity of ISB4+ fractions was >75%.
###end p 19
###begin title 20
Western blotting and pAkt[S473] enzyme-linked immunosorbent assay.
###end title 20
###begin p 21
###xml 109 110 109 110 <sub xmlns:xlink="http://www.w3.org/1999/xlink">4</sub>
###xml 111 112 111 112 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 113 114 113 114 <sub xmlns:xlink="http://www.w3.org/1999/xlink">7</sub>
###xml 127 128 127 128 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 130 131 130 131 <sub xmlns:xlink="http://www.w3.org/1999/xlink">4</sub>
###xml 368 373 <span type="species:ncbi:10090">mouse</span>
###xml 448 452 <span type="species:ncbi:9925">goat</span>
Cells were lysed in 10 mmol/l Tris, 100 mmol/l NaCl, 1 mmol/l EDTA, 1 mmol/l EGTA, 1 mmol/l NaF, 20 mmol/l Na4P2O7, 2 mmol/l Na3VO4, 1% Triton X-100, 0.1% SDS, 0.5% deoxycolate, 1 mmol/l phenylmethylsulfonyl fluoride, and Complete (Roche). Equal amounts of proteins were loaded on 4-12% SDS-PAGE gels, transferred to polyvinylidine fluoride membranes, and probed with mouse anti-promyelocitic leukemia antigen (anti-PML) (clone MAB3738; Chemicon), goat anti-adipsin (Santa Cruz Biotechnology), or anti-S100A8 (R&D Systems) antibodies. Antibody binding was revealed using an ECL-based detection system (Kirkegaard and Perry Labs). Phosphorylated pAkt[S473] and total Akt were measured by ELISA (Biosource) using 5 mug proteins.
###end p 21
###begin title 22
RNA extraction and DNA microarrays.
###end title 22
###begin p 23
RNA was extracted using RNeasy kit (Qiagen). Biotinylated cRNA was prepared using the Illumina RNA Amplification kit (Ambion), and microarray experiments were performed as detailed in the online appendix.
###end p 23
###begin title 24
Statistical analysis.
###end title 24
###begin p 25
###xml 80 83 80 83 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/&#8722;</sup>
###xml 86 89 86 89 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 135 138 135 138 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/&#8722;</sup>
###xml 141 144 141 144 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 198 199 198 199 <italic xmlns:xlink="http://www.w3.org/1999/xlink">t</italic>
###xml 320 321 320 321 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 90 94 <span type="species:ncbi:10090">mice</span>
###xml 159 163 <span type="species:ncbi:10090">mice</span>
Statistical analysis of the data between naive and bone marrow-reconstituted Id1+/-Id3-/- mice or between bone marrow-reconstituted Id1+/-Id3-/- and wild-type mice was performed using the Student's t test, and data comparing more than two groups were validated by ANOVA followed by Bonferroni's post hoc test. Data with P values <0.05 were considered statistically significant.
###end p 25
###begin title 26
RESULTS
###end title 26
###begin title 27
###xml 65 69 <span type="species:ncbi:10090">mice</span>
Failure of pancreatic islet engraftment in the Id1/Id3-deficient mice and rescue by bone marrow reconstitution.
###end title 27
###begin p 28
###xml 53 56 53 56 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/&#8722;</sup>
###xml 59 62 59 62 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 136 137 136 137 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r9">9</xref>
###xml 143 146 143 146 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/&#8722;</sup>
###xml 149 152 149 152 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 330 333 330 333 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/&#8722;</sup>
###xml 336 339 336 339 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 537 540 537 540 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/&#8722;</sup>
###xml 543 546 543 546 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 586 587 583 584 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 787 790 784 787 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/&#8722;</sup>
###xml 793 796 790 793 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 63 67 <span type="species:ncbi:10090">mice</span>
###xml 167 171 <span type="species:ncbi:10090">mice</span>
###xml 279 283 <span type="species:ncbi:10090">mice</span>
###xml 340 344 <span type="species:ncbi:10090">mice</span>
###xml 561 565 <span type="species:ncbi:10090">mice</span>
To evaluate whether bone marrow reconstitution of Id1+/-Id3-/- mice supports engraftment of pancreatic islets as seen for tumor grafts (9), Id1+/-Id3-/- and wild-type mice were reconstituted with wild-type bone marrow. To track bone marrow-derived cells, GFP transgene or ROSA26 mice were used as bone marrow donors. Untreated Id1+/-Id3-/- mice were used as controls. Fluorescence-activated cell sorter (FACS) analysis at 6 weeks after bone marrow transplantation demonstrated that >80% of the leukocytes in bone marrow-reconstituted Id1+/-Id3-/- and wild-type mice were GFP or beta-gal+, i.e., of bone marrow-donor origin. Furthermore, colony-forming unit assays and FACS analysis demonstrated that all hemopoietic lineages were reconstituted to a normal range in both wild-type and Id1+/-Id3-/- hosts (not shown).
###end p 28
###begin p 29
###xml 221 224 221 224 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/&#8722;</sup>
###xml 227 230 227 230 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 327 328 327 328 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 321 328 321 328 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f1" ref-type="fig">Fig. 1<italic>A</italic></xref>
###xml 408 411 408 411 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/&#8722;</sup>
###xml 414 417 414 417 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 430 431 430 431 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 424 431 424 431 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f1" ref-type="fig">Fig. 1<italic>B</italic></xref>
###xml 458 459 458 459 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 513 516 513 516 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/&#8722;</sup>
###xml 519 522 519 522 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 622 623 622 623 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 616 623 616 623 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f1" ref-type="fig">Fig. 1<italic>B</italic></xref>
###xml 761 762 761 762 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 811 814 811 814 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/&#8722;</sup>
###xml 817 820 817 820 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 882 885 882 885 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/&#8722;</sup>
###xml 888 891 888 891 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 904 905 904 905 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 898 905 898 905 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f1" ref-type="fig">Fig. 1<italic>C</italic></xref>
###xml 1011 1014 1011 1014 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/&#8722;</sup>
###xml 1017 1020 1017 1020 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 1108 1109 1108 1109 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 45 49 <span type="species:ncbi:10090">mice</span>
###xml 231 235 <span type="species:ncbi:10090">mice</span>
###xml 315 319 <span type="species:ncbi:10090">mice</span>
###xml 418 422 <span type="species:ncbi:10090">mice</span>
###xml 523 527 <span type="species:ncbi:10090">mice</span>
###xml 610 614 <span type="species:ncbi:10090">mice</span>
###xml 821 825 <span type="species:ncbi:10090">mice</span>
###xml 892 896 <span type="species:ncbi:10090">mice</span>
###xml 1021 1025 <span type="species:ncbi:10090">mice</span>
###xml 1160 1164 <span type="species:ncbi:10090">mice</span>
Six weeks after bone marrow engraftment, the mice were transplanted under the kidney capsule with 500 wild-type pancreatic islets. Immunostaining for insulin at 1 week after transplantation demonstrated that untreated Id1+/-Id3-/- mice harbored significantly smaller grafts than bone marrow-reconstituted wild-type mice (Fig. 1A). However, reconstitution with wild-type bone marrow rescued engraftment in Id1+/-Id3-/- mice (Fig. 1B). Furthermore, the insulin+ area of the grafts from bone marrow-reconstituted Id1+/-Id3-/- mice was >2.5-fold larger than that of grafts from bone marrow-reconstituted wild-type mice (Fig. 1B), suggesting differential islet cell survival. Morphometric analysis demonstrated approximately a twofold increase in the number of TUNEL+ apoptotic cells in islet grafts of untreated Id1+/-Id3-/- mice compared with bone marrow-reconstituted wild-type or Id1+/-Id3-/- mice (Fig. 1C). In contrast, the number of apoptotic cells in the grafts of bone marrow-reconstituted wild-type and Id1+/-Id3-/- mice was not significantly different. Even at earlier time points (i.e., 2 days), TUNEL+ islet cells were very rare in these two groups of mice (i.e., <0.1%), possibly because of efficient clearance of apoptotic cells.
###end p 29
###begin p 30
###xml 71 73 71 73 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r23">23</xref>
###xml 74 76 74 76 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r24">24</xref>
###xml 215 218 215 218 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/&#8722;</sup>
###xml 221 224 221 224 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 393 396 393 396 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/&#8722;</sup>
###xml 399 402 399 402 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 432 433 432 433 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 426 433 426 433 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f1" ref-type="fig">Fig. 1<italic>D</italic></xref>
###xml 594 597 594 597 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/&#8722;</sup>
###xml 600 603 600 603 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 780 781 780 781 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E</italic>
###xml 786 787 786 787 <italic xmlns:xlink="http://www.w3.org/1999/xlink">F</italic>
###xml 774 787 774 787 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f1" ref-type="fig">Fig. 1<italic>E</italic> and <italic>F</italic></xref>
###xml 941 943 941 943 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r25">25</xref>
###xml 1043 1046 1043 1046 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/&#8722;</sup>
###xml 1049 1052 1049 1052 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 1164 1166 1164 1166 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r26">26</xref>
###xml 1271 1273 1271 1273 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r26">26</xref>
###xml 1445 1448 1445 1448 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/&#8722;</sup>
###xml 1451 1454 1451 1454 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 1521 1522 1521 1522 <italic xmlns:xlink="http://www.w3.org/1999/xlink">G</italic>
###xml 1515 1522 1515 1522 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f1" ref-type="fig">Fig. 1<italic>G</italic></xref>
###xml 1630 1633 1630 1633 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/&#8722;</sup>
###xml 1636 1639 1636 1639 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 1669 1670 1669 1670 <italic xmlns:xlink="http://www.w3.org/1999/xlink">H</italic>
###xml 1663 1670 1663 1670 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f1" ref-type="fig">Fig. 1<italic>H</italic></xref>
###xml 1948 1951 1948 1951 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/&#8722;</sup>
###xml 1954 1957 1954 1957 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 225 229 <span type="species:ncbi:10090">mice</span>
###xml 420 424 <span type="species:ncbi:10090">mice</span>
###xml 604 608 <span type="species:ncbi:10090">mice</span>
###xml 1455 1459 <span type="species:ncbi:10090">mice</span>
###xml 1657 1661 <span type="species:ncbi:10090">mice</span>
###xml 1958 1962 <span type="species:ncbi:10090">mice</span>
Signaling by Akt positively regulates cell survival and proliferation (23,24). Therefore, we investigated whether this pathway was differentially activated in grafts of bone marrow-reconstituted wild-type versus Id1+/-Id3-/- mice. Measurement of Akt activation by detection of pAkt[S473] in islet cell lysates revealed significantly higher levels of pAkt[S473] in bone marrow-reconstituted Id1+/-Id3-/- versus wild-type mice (Fig. 1D). Furthermore, graft immunostaining demonstrated a strikingly different pattern of pAkt[S473] expression in situ. Thus, whereas in bone marrow-reconstituted Id1+/-Id3-/- mice, a strong immunoreactivity for pAkt was observed throughout the graft, in wild-type controls, only cells at the periphery of islets were strongly positive for pAkt (Fig. 1E and F, arrows). In both grafts, pAkt[S473] highlighted primarily cell nuclei and, to a lesser extent, the cytoplasm, two known localizations of activated Akt (25). The preferential nuclear localization of pAkt in the transplants of bone marrow-reconstituted Id1+/-Id3-/- resembled that of tumors lacking the PML, a tumor suppressor gene regulating cell proliferation and apoptosis (26). Consistent with the function of PML as negative regulator of Akt activation and nuclear localization (26), immunostaining for PML in islet grafts demonstrated a pattern of expression that mirrored pAkt[S473], i.e., weak labeling of islet cells in bone marrow-reconstituted Id1+/-Id3-/- mice and strong labeling of islets in wild-type recipients (Fig. 1G). Immunoblotting of islet protein extracts confirmed downregulation of PML in bone marrow-reconstituted Id1+/-Id3-/- versus wild-type mice (Fig. 1H). In both grafts, no cycling endocrine cells were detected (not shown), indicating that pAkt expression and its preferential nuclear localization were linked to cell survival rather than proliferation. Thus, rescue of transplant engraftment by bone marrow reconstitution in Id1+/-Id3-/- mice is associated with decreased islet cell death and activation of survival signals.
###end p 30
###begin title 31
Characterization of vasculature of the grafts.
###end title 31
###begin p 32
###xml 45 48 45 48 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/&#8722;</sup>
###xml 51 54 51 54 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 194 195 194 195 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 244 247 244 247 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/&#8722;</sup>
###xml 250 253 250 253 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 305 306 305 306 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 311 312 311 312 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 299 312 299 312 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f2" ref-type="fig">Fig. 2<italic>A</italic> and <italic>B</italic></xref>
###xml 322 323 322 323 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 384 387 384 387 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/&#8722;</sup>
###xml 390 393 390 393 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 467 468 467 468 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 461 468 461 468 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f2" ref-type="fig">Fig. 2<italic>A</italic></xref>
###xml 470 476 470 476 <italic xmlns:xlink="http://www.w3.org/1999/xlink">insets</italic>
###xml 627 628 627 628 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 621 628 621 628 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f1" ref-type="fig">Fig. 1<italic>A</italic></xref>
###xml 823 826 811 814 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/&#8722;</sup>
###xml 829 832 817 820 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 834 835 822 823 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 864 865 852 853 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 878 879 866 867 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 872 879 860 867 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f2" ref-type="fig">Fig. 2<italic>C</italic></xref>
###xml 55 59 <span type="species:ncbi:10090">mice</span>
###xml 293 297 <span type="species:ncbi:10090">mice</span>
###xml 394 398 <span type="species:ncbi:10090">mice</span>
###xml 858 862 <span type="species:ncbi:10090">mice</span>
Whole grafts of bone marrow-reconstituted Id1+/-Id3-/- mice at 1 week after transplant displayed approximately a twofold higher density of platelet/endothelial cell adhesion molecule-1 (PECAM-1)+ blood vessels than those of either untreated Id1+/-Id3-/- or bone marrow-reconstituted wild-type mice (Fig. 2A and B). PECAM-1+ blood vessels in the grafts of bone marrow-reconstituted Id1+/-Id3-/- mice also appeared more branched than those of wild-type controls (Fig. 2A, insets). Compared with the endocrine component, the nonendocrine (i.e., connective and inflammatory) tissue was more abundant in wild-type recipients (Fig. 1A) and less vascularized. Morphometric analysis of blood vessels within the grafts endocrine component only showed an approximately25% increase of vascular density in bone marrow-reconstituted Id1+/-Id3-/- (n = 3) versus wild-type mice (n = 4) (Fig. 2C).
###end p 32
###begin p 33
###xml 135 136 135 136 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 281 282 275 276 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 412 414 406 408 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r27">27</xref>
###xml 457 458 451 452 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 533 536 527 530 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/&#8722;</sup>
###xml 539 542 533 536 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 617 618 605 606 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 743 746 731 734 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/&#8722;</sup>
###xml 749 752 737 740 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 819 820 807 808 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 560 564 <span type="species:ncbi:10090">mice</span>
The lower vascular density in the grafts of wild-type recipients could not be attributed to irradiation, because the density of PECAM-1+ blood vessels was not significantly different in irradiated and nonirradiated recipients (i.e., = 13.3 +/- 0.25 vs. 14.1 +/- 1.3%, mean +/- SE, n = 4). Furthermore, staining with the Meca-32 antibody, preferentially labeling arterioles and venules over capillary endothelia (27), demonstrated that the density of Meca-32+ blood vessels was only slightly increased in bone marrow-reconstituted Id1+/-Id3-/- versus wild-type mice (i.e., 12.9 +/- 0.2 vs. 11.1 +/- 0.4%, mean +/- SE, n = 3). Thus, at 1 week after transplantation, the increased vascular density of islet grafts in bone marrow-reconstituted Id1+/-Id3-/- appears to be mainly accounted for by the development of a PECAM-1+ capillary network.
###end p 33
###begin p 34
###xml 94 96 94 96 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r16">16</xref>
###xml 97 99 97 99 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r17">17</xref>
###xml 179 182 179 182 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/&#8722;</sup>
###xml 185 188 185 188 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 221 222 221 222 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 215 222 215 222 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f2" ref-type="fig">Fig. 2<italic>B</italic></xref>
###xml 345 348 333 336 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/&#8722;</sup>
###xml 351 354 339 342 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 356 357 344 345 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 393 394 381 382 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 407 408 395 396 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 401 408 389 396 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f2" ref-type="fig">Fig. 2<italic>C</italic></xref>
###xml 532 535 520 523 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/&#8722;</sup>
###xml 538 541 526 529 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 687 688 675 676 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 681 688 669 676 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f2" ref-type="fig">Fig. 2<italic>C</italic></xref>
###xml 387 391 <span type="species:ncbi:10090">mice</span>
###xml 542 546 <span type="species:ncbi:10090">mice</span>
###xml 624 628 <span type="species:ncbi:10090">mice</span>
At 4 weeks after transplantation, a time when revascularization of islet grafts is completed (16,17), vascular density of whole grafts was similar in bone marrow-reconstituted Id1+/-Id3-/- and wild-type recipients (Fig. 2B); however, in the endocrine component of the grafts, it was still approximately25% higher in bone marrow-reconstituted Id1+/-Id3-/- (n = 3) compared with wild-type mice (n = 4) (Fig. 2C). When compared with islets endogenous to the pancreas, the vascular density of the grafts in bone marrow-reconstituted Id1+/-Id3-/- mice was remarkably similar at 1 week after transplantation, whereas in wild-type mice, it was always less than that of endogenous islets (Fig. 2C).
###end p 34
###begin p 35
###xml 29 32 29 32 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/&#8722;</sup>
###xml 35 38 35 38 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 100 103 100 103 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/&#8722;</sup>
###xml 106 109 106 109 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 124 125 124 125 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 118 125 118 125 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f2" ref-type="fig">Fig. 2<italic>C</italic></xref>
###xml 219 220 219 220 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r9">9</xref>
###xml 221 223 221 223 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r20">20</xref>
###xml 224 226 224 226 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r21">21</xref>
###xml 227 229 227 229 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r28">28</xref>
###xml 355 357 355 357 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r29">29</xref>
###xml 358 360 358 360 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r30">30</xref>
###xml 511 514 511 514 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/&#8722;</sup>
###xml 517 520 517 520 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 690 691 690 691 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 684 691 684 691 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f2" ref-type="fig">Fig. 2<italic>C</italic></xref>
###xml 39 43 <span type="species:ncbi:10090">mice</span>
###xml 521 525 <span type="species:ncbi:10090">mice</span>
###xml 678 682 <span type="species:ncbi:10090">mice</span>
Bone marrow-reconstituted Id1+/-Id3-/- mice also efficiently revascularized islets isolated from Id1+/-Id3-/- donors (Fig. 2C). We hypothesized that because of the growth defects of Id1/Id3-deficient endothelial cells (9,20,21,28), these transplants would unlikely be supported by islet donor-derived endothelial cells that might survive islet isolation (29,30). Under these conditions, two of three grafts failed to engraft in wild-type recipients. In contrast, all transplants in bone marrow-reconstituted Id1+/-Id3-/- mice engrafted and, at 4 weeks after transplant, displayed approximately a twofold higher vascular density than the single transplant engrafted in wild-type mice (Fig. 2C).
###end p 35
###begin p 36
###xml 120 123 120 123 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/&#8722;</sup>
###xml 126 129 126 129 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 166 169 166 169 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/&#8722;</sup>
###xml 172 175 172 175 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 201 202 201 202 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 195 202 195 202 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f2" ref-type="fig">Fig. 2<italic>D</italic></xref>
###xml 209 210 209 210 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 423 424 423 424 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 428 429 428 429 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 532 533 532 533 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 594 597 594 597 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/&#8722;</sup>
###xml 600 603 600 603 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 640 641 640 641 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 645 646 645 646 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 674 675 674 675 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 750 751 750 751 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 814 815 814 815 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 130 134 <span type="species:ncbi:10090">mice</span>
###xml 176 180 <span type="species:ncbi:10090">mice</span>
###xml 396 400 <span type="species:ncbi:10090">mice</span>
###xml 604 608 <span type="species:ncbi:10090">mice</span>
In vivo injection of FITC-ISB4 demonstrated that blood vessels developing in bone marrow-reconstituted wild-type and Id1+/-Id3-/- mice, but not those in untreated Id1+/-Id3-/- mice, were patent (Fig. 2D). ISB4+ blood vessels coexpressed the endothelial marker PECAM-1 but not the pan-leukocyte antigen CD45 (not shown). FACS analysis of cells dissociated from the grafts showed that in wild-type mice, 78 and 89% of PECAM-1+CD45- cells displayed bound ISB4 at 1 and 4 weeks after transplantation, respectively (Supplementary Fig. S1C [online appendix]); whereas in bone marrow-reconstituted Id1+/-Id3-/- mice, a higher proportion of PECAM-1+CD45- endothelial cells were ISB4+ at either time point (i.e., 91 and 98% respectively; Supplementary Fig. S1D). These results indicate that although the majority of PECAM-1+ cells detected in situ outline functional vessels, some do not. This latter fraction, possibly part of developing vascular structures yet not blood-perfused, is higher at 1 than at 4 weeks after transplantation in either graft and in the grafts of wild-type recipients at either time point.
###end p 36
###begin p 37
###xml 52 55 49 52 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/&#8722;</sup>
###xml 58 61 55 58 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 143 144 140 141 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 172 173 166 167 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 218 219 212 213 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E</italic>
###xml 212 219 206 213 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f2" ref-type="fig">Fig. 2<italic>E</italic></xref>
###xml 263 264 254 255 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 535 536 526 527 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 607 609 598 600 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r31">31</xref>
###xml 813 814 804 805 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 62 66 <span type="species:ncbi:10090">mice</span>
###xml 692 696 <span type="species:ncbi:10090">mice</span>
Immunostaining for beta-gal in islet grafts from Id1+/-Id3-/- mice reconstituted with ROSA26 bone marrow demonstrated that the majority of ISB4+ blood vessels were beta-gal+, indicating their bone marrow origin (Fig. 2E). In contrast, bone marrow-derived beta-gal+ endothelial cells were virtually undetectable in wild-type recipients reconstituted with ROSA26 bone marrow. Ultrastructurally, bone marrow-derived blood vessels appear as small capillaries lined by a fenestrated endothelium and perivascular cells (Supplementary Fig. S2A) reminiscent of the capillaries of islets in the endogenous pancreas (31). In contrast, blood vessels in the grafts of bone marrow-reconstituted wild-type mice appeared larger and lined by a fenestrated endothelium loosely attached to the basal membrane (Supplementary Fig. S2B, asterisks).
###end p 37
###begin p 38
###xml 118 121 118 121 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/&#8722;</sup>
###xml 124 127 124 127 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 128 132 <span type="species:ncbi:10090">mice</span>
###xml 314 318 <span type="species:ncbi:10090">mice</span>
These results demonstrate that enhanced survival and engraftment of islet transplants in bone marrow-reconstituted Id1+/-Id3-/- mice correlates with a predominant bone marrow-derived vasculogenic component and rapid development of a functional, dense capillary network. In contrast, new blood vessels in wild-type mice are formed primarily from the preexisting tissue-derived vasculature and expand less efficiently into blood-perfused capillaries.
###end p 38
###begin title 39
###xml 105 109 105 109 <sup xmlns:xlink="http://www.w3.org/1999/xlink">high</sup>
###xml 113 114 113 114 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
Graft revascularization by bone marrow-derived endothelium is associated with enhanced recruitment of GR1highF480+ inflammatory cells and with the activation of repair response genes.
###end title 39
###begin p 40
###xml 42 43 42 43 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 51 52 48 49 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 140 141 134 135 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 299 300 293 294 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 314 315 308 309 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 308 315 302 309 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f3" ref-type="fig">Fig. 3<italic>A</italic></xref>
###xml 386 387 368 369 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 395 399 377 381 <sup xmlns:xlink="http://www.w3.org/1999/xlink">high</sup>
###xml 403 404 385 386 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 491 494 473 476 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/&#8722;</sup>
###xml 497 500 479 482 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 539 540 521 522 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 545 546 527 528 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 533 546 515 528 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f3" ref-type="fig">Fig. 3<italic>B</italic> and <italic>C</italic></xref>
###xml 548 549 530 531 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 555 556 537 538 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 758 759 740 741 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 752 759 734 741 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f3" ref-type="fig">Fig. 3<italic>D</italic></xref>
###xml 761 762 743 744 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 108 112 <span type="species:ncbi:10090">mice</span>
###xml 501 505 <span type="species:ncbi:10090">mice</span>
###xml 695 699 <span type="species:ncbi:10090">mice</span>
At 1 week after transplantation, many CD45+beta-gal+ inflammatory leukocytes were observed in the grafts of mice reconstituted with beta-gal+ bone marrow (Supplementary Fig. S3). Peri-islet inflammatory cells were present in both Id1/Id3-deficient and wild-type recipients and comprised myeloid F480+ cells (Fig. 3A). FACS analysis demonstrated an approximately2.5-fold increase in F480+ and GR1highF480+ cells in the grafts, but not bone marrow compartment, of bone marrow-reconstituted Id1+/-Id3-/- mice versus wild-type controls (Fig. 3B and C; n = 4, P < 0.002). Numbers of T- and B-cells were similar in the two grafts at 1 week after transplantation, whereas grafts from Id1/Id3-deficient mice had fewer T-cells at 4 weeks after transplantation (Fig. 3D, n = 2).
###end p 40
###begin p 41
###xml 280 281 280 281 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 290 291 290 291 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 450 453 450 453 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/&#8722;</sup>
###xml 456 459 456 459 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 567 574 567 574 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="t1">Table 1</xref>
###xml 576 582 576 582 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f4" ref-type="fig">Fig. 4</xref>
###xml 775 778 775 778 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/&#8722;</sup>
###xml 781 784 781 784 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 961 962 961 962 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 971 972 971 972 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1013 1016 1013 1016 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/&#8722;</sup>
###xml 1019 1022 1019 1022 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 1326 1328 1322 1324 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r32">32</xref>
###xml 1531 1533 1527 1529 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r33">33</xref>
###xml 1534 1536 1530 1532 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r34">34</xref>
###xml 2007 2013 2003 2009 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f4" ref-type="fig">Fig. 4</xref>
###xml 162 166 <span type="species:ncbi:10090">mice</span>
###xml 477 481 <span type="species:ncbi:10090">mice</span>
###xml 785 789 <span type="species:ncbi:10090">mice</span>
###xml 1023 1027 <span type="species:ncbi:10090">mice</span>
###xml 1626 1630 <span type="species:ncbi:10090">mice</span>
To gain insights into the genetic program activated within the distinct vascular and inflammatory transplant microenvironments in Id1/Id3-deficient and wild-type mice, we performed gene-screening experiments using RNA from whole grafts and from myeloid and endothelial (i.e., CD31+ and ISB4+) cells isolated from the grafts at 1 week after transplantation. Analysis of transcripts exhibiting more than twofold changes in bone marrow-reconstituted Id1+/-Id3-/- versus wild-type mice demonstrated differential expression of inflammation and angiogenesis-related genes (Table 1; Fig. 4). First, a significant decreased expression of complement components and adipokines, including adipsin, adiponectin, and leptin, was observed in whole grafts from bone marrow-reconstituted Id1+/-Id3-/- mice. Conversely, genes regulating the influx and function of neutrophils, monocytes, and eosinophils (e.g., CCL1, CCL2, CCL7, and Calgranulin A and B) were upregulated in CD31+ and ISB4+ samples of bone marrow-reconstituted Id1+/-Id3-/- mice. Most remarkably, in these samples, we observed an increased expression of genes marking macrophages polarized toward type II immune responses (e.g., resistitin-like molecule-alpha, interleukin [IL]-10, Chitinase 3-like molecules, CCL24, signaling lymphocytic activation molecule, and Arginase I) (32) and anti-inflammatory genes involved in the response to pathogens, oxidative stress, and wound healing (e.g., trefoil factors, serine peptidase inhibitors, cathelicidin, and glutathione peroxidase 2) (33,34). Angiogenesis-related genes were also upregulated in Id1/Id3-deficient versus wild-type mice and included adhesion receptors to extracellular matrix (ECM) proteins (Thy-1, Spondin 2, and SPARC [secreted protein, acidic, and rich in cysteine]), proangiogenic ECMs and remodeling enzymes (procollagen type VI, MMP7 [matrix metalloproteinase-7], and TIMP1 [tissue inhibitor of metalloproteinase]), and molecules regulating endothelial cell proliferation (CXCR3 and IL-6) (Fig. 4). Differential protein expression of select genes was confirmed by immunohistochemistry, immunoblotting, and/or ELISA (Supplementary Fig. S4). These findings demonstrate that compared with the tissue-derived vasculature, bone marrow-derived vascular cells are associated with an inflammatory component enriched for myeloid cells and functionally skewed toward protective immune responses and tissue repair.
###end p 41
###begin title 42
Islet transplants revascularized by bone marrow-derived vasculogenic cells readily reverse diabetes in vivo.
###end title 42
###begin p 43
###xml 358 361 358 361 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/&#8722;</sup>
###xml 364 367 364 367 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 493 494 493 494 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 487 494 487 494 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f5" ref-type="fig">Fig. 5<italic>A</italic></xref>
###xml 627 630 627 630 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/&#8722;</sup>
###xml 633 636 633 636 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 960 961 960 961 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 954 961 954 961 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f5" ref-type="fig">Fig. 5<italic>B</italic></xref>
###xml 1108 1111 1108 1111 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/&#8722;</sup>
###xml 1114 1117 1114 1117 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 1156 1157 1156 1157 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 1162 1163 1162 1163 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 1150 1163 1150 1163 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f5" ref-type="fig">Fig. 5<italic>C</italic> and <italic>D</italic></xref>
###xml 1271 1272 1271 1272 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 1453 1454 1449 1450 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 1685 1686 1681 1682 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 2036 2039 2029 2032 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/&#8722;</sup>
###xml 2042 2045 2035 2038 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 2246 2249 2239 2242 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/&#8722;</sup>
###xml 2252 2255 2245 2248 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 382 386 <span type="species:ncbi:10090">mice</span>
###xml 562 566 <span type="species:ncbi:10090">mice</span>
###xml 637 641 <span type="species:ncbi:10090">mice</span>
###xml 912 916 <span type="species:ncbi:10090">mice</span>
###xml 1118 1122 <span type="species:ncbi:10090">mice</span>
###xml 1144 1148 <span type="species:ncbi:10090">mice</span>
###xml 1174 1178 <span type="species:ncbi:10090">mice</span>
###xml 1372 1376 <span type="species:ncbi:10090">mice</span>
###xml 1784 1788 <span type="species:ncbi:10090">mice</span>
###xml 2046 2050 <span type="species:ncbi:10090">mice</span>
###xml 2256 2260 <span type="species:ncbi:10090">mice</span>
To evaluate the translational implications of the enhanced angiogenic and repairing functions associated with bone marrow-derived vasculogenic cells at sites of islet transplantation, we induced diabetes in the Id1/Id3-deficient strain by streptozotocin and then assessed the ability of islet transplants to reverse hyperglycemia. Streptozotocin-injected Id1+/-Id3-/- and wild-type mice became hyperglycemic by 72 h after injection and remained diabetic up to a 4-week follow-up period (Fig. 5A). After this time point, the experiment was ended because diabetic mice would not survive without treatment. Next, wild-type and Id1+/-Id3-/- mice were reconstituted with wild-type bone marrow, rendered diabetic by streptozotocin, and transplanted with either 500, 200, or 75 islets 1 week later. Daily monitoring of blood glucose demonstrated that transplants of 500 islets effectively restored normoglycemia in all mice within 1 week after transplantation (Fig. 5B). Interestingly, transplants of 200 and as few as 75 islets were also sufficient to rapidly restore normoglycemia in bone marrow-reconstituted Id1+/-Id3-/- mice but not in wild-type mice (Fig. 5C and D). Control mice (i.e., not transplanted) remained diabetic over the study period (blood glucose >400 mg/dl, n = 2; data not shown). Furthermore, removal of the grafts at 3 weeks after transplantation in cured mice led to recurrence of diabetes (blood glucose 283 +/- 47 mg/dl, mean +/- SE, n = 8), confirming the functionality of the grafts and the lack of functional recovery of the endogenous islets from streptozotocin-mediated destruction. In addition, insulin immunostaining of pancreata revealed that remnant insulin+ areas were not significantly different in streptozotocin-treated wild-type and Id1/Id3-deficient mice (not shown), indicating that there was no differential beta-cell recovery within the 4 weeks after transplant period. Further experiments showed that serum insulin and adiponectin and response to insulin challenge were similar in wild-type and Id1+/-Id3-/- mice (Supplementary Fig. S5), indicating that differential peripheral insulin sensitivity did not account for the observed diabetes reversal by small islet transplants in bone marrow-reconstituted Id1+/-Id3-/- mice.
###end p 43
###begin p 44
These results demonstrate that the enhanced contribution of bone marrow-derived cells to islet revascularization has a significant impact on transplant engraftment and function, allowing even a limited number of islets to reverse diabetes in transplant recipients.
###end p 44
###begin title 45
DISCUSSION
###end title 45
###begin p 46
###xml 130 131 130 131 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r2">2</xref>
Bone marrow-derived vascular cells have been proposed as targetable cell types for drug or gene delivery and for vascular repair (2). However, conditions permissive to the substantial recruitment of these cells in nontumoral tissues remain to be defined. Furthermore, it is uncertain whether such vasculature would support normal tissue functions. Here, we show that functional bone marrow-derived blood vessels can develop within pancreatic islet grafts and that Id1/Id3 defective expression at transplantation sites is required for this phenomenon. Neovascularization by bone marrow-derived vasculogenic cells is associated with enhanced islets' vascular density and improved graft survival and function, demonstrating a biological advantage over the tissue-derived vasculature. Moreover, the downregulation of genes involved in tissue damage and the activation of protective repairing responses observed in these grafts provide evidence for a role of bone marrow-derived cells in antagonizing pathogenic inflammation and promoting tissue healing.
###end p 46
###begin p 47
###xml 171 172 171 172 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r9">9</xref>
###xml 173 175 173 175 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r20">20</xref>
###xml 176 178 176 178 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r22">22</xref>
###xml 179 181 179 181 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r35">35</xref>
###xml 485 487 485 487 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r36">36</xref>
###xml 806 808 806 808 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r37">37</xref>
###xml 809 811 809 811 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r38">38</xref>
###xml 1107 1109 1107 1109 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r39">39</xref>
###xml 1110 1112 1110 1112 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r40">40</xref>
###xml 1710 1712 1706 1708 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r41">41</xref>
###xml 1713 1715 1709 1711 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r42">42</xref>
###xml 610 614 <span type="species:ncbi:10090">mice</span>
The vascular contribution of bone marrow-derived vasculogenic cells varies greatly in tumors of different origin and grades and in transplanted versus spontaneous tumors (9,20,22,35). These observations predict that recruitment and development of these progenitors may also differ among quiescent tissues. We demonstrate herein that islet transplants supports vascular development of bone marrow-derived cells. Angiogenic factors of islets, such as vascular endothelial growth factor (36), may contribute to this effect. Yet, these factors may not be sufficient, because the same tissue engrafted in wild-type mice harbored virtually no bone marrow-derived blood vessels. Accordingly, previous reports have shown a few bone marrow-derived vascular cells in models of islet transplantation or islet injury (37,38). In addition, overexpression of proangiogenic factors and/or use of progenitors mobilizing agents, although enhancing local accumulation of various bone marrow-derived cell lineages, do not necessarily result in increased incorporation of bone marrow-derived vascular cells into blood vessels (39,40). Thus, in a wild-type environment, the development of bone marrow-derived vascular progenitors at sites of healing appears to be tightly regulated by unknown local homeostatic mechanisms. These tissue barriers are clearly overcome by downregulation of Id1 and Id3 at transplantation sites, providing a niche for bone marrow cells to home and/or expand. In this regard, it is noteworthy that Id1 in endothelial cells regulates expression of chondroitin sulfate proteoglycan and HIF1alpha, factors previously involved in the recruitment and/or development of bone marrow-derived endothelial cells (41,42). Hence, downregulation of Id1 and Id3 at transplantation sites (e.g., by retrovirus-mediated small interfering RNAs delivered to the local vasculature) may be envisaged as a therapeutic strategy to facilitate homing/development of bone marrow cells with high vasculogenic potential, thereby improving engraftment and function of cell transplants.
###end p 47
###begin p 48
###xml 371 372 371 372 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r1">1</xref>
###xml 919 923 919 923 <sup xmlns:xlink="http://www.w3.org/1999/xlink">high</sup>
###xml 927 928 927 928 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1040 1041 1040 1041 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1095 1097 1095 1097 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r43">43</xref>
###xml 1157 1159 1157 1159 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r44">44</xref>
###xml 1172 1176 1172 1176 <sup xmlns:xlink="http://www.w3.org/1999/xlink">high</sup>
###xml 1180 1181 1180 1181 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 2339 2341 2339 2341 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r45">45</xref>
###xml 2189 2193 <span type="species:ncbi:10090">mice</span>
Although our studies uncover distinct engrafting and angiogenic functions of bone marrow-derived versus tissue-derived vasculogenic cells in islet transplants, they do not address to what extent these properties are contributed by the vascular cells and/or by associated inflammatory leukocytes. Vascular and inflammatory cells regulate each other during tissue healing (1). Further studies are warranted to determine how these complex cellular networks influence engraftment. Nevertheless, our gene-screening experiments provide important clues on the cell types and molecular pathways possibly involved. Thus, a hallmark of the grafts supported by bone marrow-derived blood vessels is the increased expression of genes regulating the influx, activation, and angiogenic function of neutrophils and monocytes. Consistent with an increased frequency of these myeloid subsets, these grafts harbored a higher number of GR1highF480+ cells. In addition, fewer T-cells were observed in those transplants. Interestingly, there is evidence that GR1+ leukocytes regulate the angiogenic switch in tumors (43) and that T-cells control vascular pruning and remodeling (44). Hence, GR1highF480+ cells may contribute to the enhanced angiogenic response of the bone marrow-derived vasculature, whereas the low number of T-cells recruited and/or surviving locally may be permissive to the expansion of that vascular network in the islet grafts. The increased expression of genes marking the activation of M2 polarized macrophages and antioxidative pathways point to other biological responses that may also positively affect engraftment. Importantly, this M2-polarized gene profile was not detected in peripheral macrophages (not shown), indicating that it was not dictated by the Id1/Id3-deficient environment per se. This pattern provides strong evidence that bone marrow-derived vascular cells are associated with and/or may support protective repairing rather than harmful inflammatory responses at sites of tissue injury. Finally, noteworthy for its direct implications on transplant survival is the downregulation of Factor D (adipsin) in the grafts from bone marrow-reconstituted Id1/Id3-deficient mice. Adipsin is the limiting factor for the activation of the alternative pathway of complement, reportedly involved in ischemia/reperfusion injury (45). The downregulation of this factor suggests that the microenvironment contributed by bone marrow-derived vasculogenic cells modulates the susceptibility of islet tissue to damage by complement.
###end p 48
###begin p 49
###xml 1119 1122 1116 1119 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/&#8722;</sup>
###xml 1125 1128 1122 1125 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 1322 1324 1319 1321 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r26">26</xref>
###xml 1325 1327 1322 1324 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r46">46</xref>
###xml 165 173 <span type="species:ncbi:9606">patients</span>
###xml 722 726 <span type="species:ncbi:10090">mice</span>
###xml 1129 1133 <span type="species:ncbi:10090">mice</span>
Islet transplantation has the potential to replace pancreatic endocrine function in type 1 diabetics. However, the large beta-cell mass required to treat individual patients has precluded the wide use of this approach. Our studies provide in vivo evidence that neovascularization by bone marrow-derived vasculogenic cells confers a significant survival advantage to islet transplants, allowing fewer islets to promptly reestablish normoglycemia in diabetic recipients. It will be important to determine in future studies whether bone marrow-derived endothelial progenitors can similarly enhance islet engraftment at other transplantation sites (e.g., the liver) and in models of allotransplantation in autoimmune diabetic mice. Notwithstanding, the syngeneic system presented here demonstrates that in the absence of a substantial input from this bone marrow vasculogenic component, the angiogenic response of the tissue vasculature appears insufficient to ensure survival throughout the graft, as inferred from the heterogeneous pAkt expression observed in situ. Notably, in the grafts of bone marrow-reconstituted Id1+/-Id3-/- mice, strong expression of nuclear pAkt inversely correlated with PML. This tumor suppressor gene opposes pAkt nuclear functions and negatively regulates responses to hypoxia and angiogenesis (26,46). Hence, PML downregulation within islet grafts is consistent with a coordinated activation of survival and proangiogenic signals.
###end p 49
###begin p 50
In conclusion, these studies provide strong evidence that enhancing the contribution of bone marrow-derived vasculogenic cells is a promising therapeutic approach to improve recovery of pancreatic islets after transplant. Furthermore, the association of bone marrow-derived vascular cells with protective inflammatory responses shown here may have implications in transplant tolerance.
###end p 50
###begin title 51
Supplementary Material
###end title 51
###begin title 52
Online-Only Appendix
###end title 52
###begin p 53
V.C. has received support from the Juvenile Diabetes Research Foundation (JDRF) and Larry L. Hillblom Foundation Research Grants. G.R.D. has received support from the JDRF and Larry L. Hillblom Foundation Research Grants. G.H. has received NIH/NIDDK Award 1 P30-DK-063491-03. B.E.T. has received Defense Advanced Research Projects Agency Grant W81XWH-04 C-0139. L.C. has received National Institutes of Health (NIH) Pilot Grant VU/U19 DK42502, a JDRF International Innovative Grant, and NIH Grant RO1-HL-075270. Confocal and electron microscopy was performed at the National Center for Microscopy and Imaging Research supported by NIH Grant P41-RR-004050 to Dr. M. Ellisman.
###end p 53
###begin p 54
We thank Dr. G. Del Zoppo (TSRI) and Dr. H. Powell (University of California San Diego [UCSD]) for their advice on tissue histology. We thank J. Lapira and Dr. Roman Sasik at the UCSD Biomedical Genomics Microarray Facility laboratory for Illumina Beadarray processing and bioinformatics analysis.
###end p 54
###begin title 55
REFERENCES
###end title 55
###begin p 56
###xml 39 42 39 42 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/&#8722;</sup>
###xml 45 48 45 48 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 165 166 165 166 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 333 336 333 336 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/&#8722;</sup>
###xml 339 342 339 342 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 349 361 349 361 <italic xmlns:xlink="http://www.w3.org/1999/xlink">middle panel</italic>
###xml 473 474 473 474 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 539 542 539 542 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/&#8722;</sup>
###xml 545 548 545 548 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 555 558 555 558 <italic xmlns:xlink="http://www.w3.org/1999/xlink">top</italic>
###xml 563 576 563 576 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bottom panels</italic>
###xml 579 580 579 580 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 643 644 643 644 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 765 792 764 791 <sc xmlns:xlink="http://www.w3.org/1999/xlink">research design and methods</sc>
###xml 889 890 886 887 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 907 908 904 905 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 1047 1048 1042 1043 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 1097 1098 1092 1093 <italic xmlns:xlink="http://www.w3.org/1999/xlink">t</italic>
###xml 1207 1208 1202 1203 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 1252 1256 1247 1251 <italic xmlns:xlink="http://www.w3.org/1999/xlink">left</italic>
###xml 1273 1278 1268 1273 <italic xmlns:xlink="http://www.w3.org/1999/xlink">right</italic>
###xml 1420 1421 1413 1414 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 1444 1445 1437 1438 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E</italic>
###xml 1539 1542 1532 1535 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/&#8722;</sup>
###xml 1545 1548 1538 1541 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 1550 1559 1543 1552 <italic xmlns:xlink="http://www.w3.org/1999/xlink">top panel</italic>
###xml 1686 1698 1679 1691 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bottom panel</italic>
###xml 1792 1793 1785 1786 <italic xmlns:xlink="http://www.w3.org/1999/xlink">F</italic>
###xml 1929 1930 1922 1923 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1945 1946 1938 1939 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1979 1982 1972 1975 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/&#8722;</sup>
###xml 1985 1988 1978 1981 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 1995 2004 1988 1997 <italic xmlns:xlink="http://www.w3.org/1999/xlink">top panel</italic>
###xml 2028 2029 2021 2022 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 2072 2084 2065 2077 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bottom panel</italic>
###xml 2087 2092 2080 2085 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Inset</italic>
###xml 2179 2180 2172 2173 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 2193 2194 2186 2187 <italic xmlns:xlink="http://www.w3.org/1999/xlink">G</italic>
###xml 2359 2362 2352 2355 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/&#8722;</sup>
###xml 2365 2368 2358 2361 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 2370 2379 2363 2372 <italic xmlns:xlink="http://www.w3.org/1999/xlink">top panel</italic>
###xml 2420 2421 2413 2414 <italic xmlns:xlink="http://www.w3.org/1999/xlink">H</italic>
###xml 49 53 <span type="species:ncbi:10090">mice</span>
###xml 343 347 <span type="species:ncbi:10090">mice</span>
###xml 549 553 <span type="species:ncbi:10090">mice</span>
###xml 895 899 <span type="species:ncbi:10090">mice</span>
###xml 1053 1057 <span type="species:ncbi:10090">mice</span>
###xml 1680 1684 <span type="species:ncbi:10090">mice</span>
###xml 1989 1993 <span type="species:ncbi:10090">mice</span>
###xml 2614 2618 <span type="species:ncbi:10090">mice</span>
Rescue of transplant engraftment in Id1+/-Id3-/- mice by reconstitution with wild-type bone marrow is associated with the activation of islet cell survival signals. A: Graft tissue sections at 1 week after transplantation stained by immunoperoxidase for insulin (brown). Scar tissue occupies the transplantation site in untreated Id1+/-Id3-/- mice (middle panel, area bordered by dotted line), indicating failure of islet engraftment. In contrast, grafts containing insulin+ cells are present in bone marrow-reconstituted wild-type and Id1+/-Id3-/- mice (top and bottom panels). B: Morphometric analysis of whole grafts (top graph) and insulin+ areas (bottom graph) measured in multiple sections collected at 100-mum intervals throughout the grafts as described in research design and methods. Each bar represents the mean +/- SE of measurements from 80-120 tissue sections per group with n = 4 mice/group. C: Quantitative analysis of apoptotic cells detected by TUNEL at 1 week after transplantation. Values are means +/- SE of measurements from n = 3 mice per group. Statistical significance by t test is indicated. Significance was also validated by ANOVA and Bonferroni post hoc test (online appendix). D: Quantitative determination of pAkt[S473] (left) and total Akt (right) detected by ELISA in lysates of islet clusters microdissected from the grafts. Values are means +/- SE of triplicate samples from a pool of n = 2 grafts per group. E: Tissue sections stained for pAkt[S473] by immunoperoxidase. In bone marrow-reconstituted Id1+/-Id3-/- (top panel), virtually all cells within islet cell clusters (dotted areas) express high levels of pAkt[S473], whereas in wild-type mice (bottom panel), only cells at the periphery of the clusters (arrows) are strongly positive for pAkt[S473]. F: Confocal microscopy of tissues sections stained by two-color immunofluorescence for pAkt[S473] (red) and insulin (green). Most insulin+ cells are pAkt+ in bone marrow-reconstituted Id1+/-Id3-/- mice (top panel), whereas fewer insulin+ cells express pAkt in wild-type controls (bottom panel). Inset represents background staining by control IgGs. Immunostainings are representative of n = 3 grafts. G: Tissue sections stained for PML by immunoperoxidase. Weak expression of PML in nuclei and cytoplasm of islet cells from the grafts of bone marrow-reconstituted Id1+/-Id3-/- (top panel) mirrors pAkt[S473] expression pattern. H: Western blotting of PML and beta-actin in protein lysates of islet cell clusters microdissected from the grafts demonstrates differential expression of PML in wild-type and Id1/Id3-deficient mice. (Please see  for a high-quality digital representation of this image.)
###end p 56
###begin p 57
###xml 184 187 184 187 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/&#8722;</sup>
###xml 190 193 190 193 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 214 215 214 215 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 391 394 391 394 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/&#8722;</sup>
###xml 397 400 397 400 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 426 429 426 429 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/&#8722;</sup>
###xml 432 435 432 435 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 456 462 456 462 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Insets</italic>
###xml 507 508 507 508 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 513 514 513 514 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 548 549 548 549 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 588 589 588 589 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 608 609 608 609 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 649 650 649 650 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 765 770 765 770 <italic xmlns:xlink="http://www.w3.org/1999/xlink">right</italic>
###xml 1204 1205 1202 1203 <italic xmlns:xlink="http://www.w3.org/1999/xlink">t</italic>
###xml 1314 1315 1312 1313 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 1542 1543 1540 1541 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E</italic>
###xml 1611 1614 1609 1612 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/&#8722;</sup>
###xml 1617 1620 1615 1618 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 1800 1801 1792 1793 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1885 1888 1877 1880 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/&#8722;</sup>
###xml 1891 1894 1883 1886 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 1977 1978 1966 1967 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 2082 2083 2071 2072 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 208 212 <span type="species:ncbi:10090">mice</span>
###xml 401 405 <span type="species:ncbi:10090">mice</span>
###xml 450 454 <span type="species:ncbi:10090">mice</span>
###xml 722 726 <span type="species:ncbi:10090">mice</span>
###xml 1368 1372 <span type="species:ncbi:10090">mice</span>
###xml 1635 1639 <span type="species:ncbi:10090">mice</span>
###xml 1895 1899 <span type="species:ncbi:10090">mice</span>
Bone marrow-derived vasculogenic cells form a dense network of functional blood vessels and differentially contribute to islet grafts revascularization in bone marrow-reconstituted Id1+/-Id3-/- and wild-type mice. A: Grafts tissue sections at 1 week after transplantation stained by immunoperoxidase for PECAM-1 demonstrates a higher density of blood vessels in bone marrow-reconstituted Id1+/-Id3-/- mice versus untreated Id1+/-Id3-/- and wild-type mice. Insets are enlarged areas of the displayed images. B and C: Morphometric analysis of PECAM-1+ blood vessel density in whole grafts (B) and islets only (C) at 1 and 4 weeks after transplant. In C, the vascular density of islets endogenous to pancreata from wild-type mice is shown for comparison (brown bar at right). Islet tissue was identified by hematoxylin counterstaining and calculated areas verified by immunostaining for synaptophysin in consecutive sections. Values marked by * were derived from one surviving graft in a group of three where the two other grafts failed and were therefore unavailable for morphometric determination. Values are means +/- SE of measurements from 80-120 tissue sections per group. Statistical significance by t test is indicated. Significance was also validated by ANOVA and Bonferroni post hoc test (online appendix). D: Confocal microscopy of grafts tissue sections from mice at 4 weeks after transplantation injected intravenously with FITC-ISB4 (green) to identify functional blood vessels and stained by immunofluorescence for insulin (red). E: To track the bone marrow origin of vascular endothelial cells, Id1+/-Id3-/- and wild-type mice were reconstituted with ROSA26 bone marrow, expressing beta-gal in all nucleated cells. Labeling of blood vessels by ISB4 (green) and immunostaining of beta-gal+ cells (red) demonstrates that grafts blood vessels in bone marrow-reconstituted Id1+/-Id3-/- mice are of bone marrow origin (arrows). In contrast, bone marrow-derived beta-gal+ endothelial cells are undetectable in the grafts of wild-type recipients. Images are representative of n = 4 grafts. (Please see  for a high-quality digital representation of this image.)
###end p 57
###begin p 58
###xml 58 59 58 59 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 141 144 141 144 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/&#8722;</sup>
###xml 147 150 147 150 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 333 338 333 338 <italic xmlns:xlink="http://www.w3.org/1999/xlink">inset</italic>
###xml 698 699 698 699 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 735 736 735 736 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 949 953 949 953 <sup xmlns:xlink="http://www.w3.org/1999/xlink">high</sup>
###xml 957 958 957 958 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1010 1013 1010 1013 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/&#8722;</sup>
###xml 1016 1019 1016 1019 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 1171 1172 1171 1172 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 1190 1191 1190 1191 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 1196 1197 1196 1197 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 1227 1231 1227 1231 <sup xmlns:xlink="http://www.w3.org/1999/xlink">high</sup>
###xml 1235 1236 1235 1236 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1244 1245 1244 1245 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1328 1331 1328 1331 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/&#8722;</sup>
###xml 1334 1337 1334 1337 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 1422 1423 1420 1421 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 151 155 <span type="species:ncbi:10090">mice</span>
###xml 1020 1024 <span type="species:ncbi:10090">mice</span>
###xml 1128 1133 <span type="species:ncbi:10090">mouse</span>
###xml 1352 1356 <span type="species:ncbi:10090">mice</span>
Detection of inflammatory leukocytes in the islet grafts. A: Tissue sections from islet grafts of bone marrow-reconstituted wild-type and Id1+/-Id3-/- mice, at 1 and 4 weeks after transplantation, stained by two-color immunohistochemistry for the pan-leukocyte marker CD45 (blue) and the myeloid marker F480 (brown) or control IgGs (inset). A leukocytic inflammatory infiltrate, comprising myeloid cells is apparent in the grafts from both experimental groups. The dotted lines mark the border of the grafts with the kidney. The intense blue staining in the kidney is background due to color development by the alkaline phosphatase endogenous to the kidney epithelium. Images are representative of n = 3 grafts per experimental group. B: Flow cytometric analysis of leukocytes isolated from the grafts at 1 and 4 weeks after transplantation stained by two-color immunofluorescence for the myeloid markers GR1 and F480. An increased percentage of GR1highF480+ cells in the graft of bone marrow-reconstituted Id1+/-Id3-/- mice is evident compared with wild-type controls. Theses cells are not present in the bone marrow of either mouse. The dot plots are representative of n = 4 experiments. C and D: Quantitative analysis of GR1highF480+ and CD3+ cell subsets detected by flow cytometry in the graft bone marrow-reconstituted Id1+/-Id3-/- and wild-type mice at 1 and 4 weeks after transplantation. Bars are means +/- SE of n = 4 independent determinations. (Please see  for a high-quality digital representation of this image.)
###end p 58
###begin p 59
###xml 114 117 114 117 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/&#8722;</sup>
###xml 120 123 120 123 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 328 331 328 331 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/&#8722;</sup>
###xml 334 337 334 337 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 124 128 <span type="species:ncbi:10090">mice</span>
###xml 338 342 <span type="species:ncbi:10090">mice</span>
Heatmaps of genes differentially expressed in whole grafts and cellular fractions of bone marrow-reconstituted Id1+/-Id3-/- mice over wild-type controls. Genes were grouped as inflammatory, repair, and angiogenesis-related genes. Fold changes between gene expression levels in samples obtained from bone marrow-reconstituted Id1+/-Id3-/- mice over those of wild-type controls are presented in the form of a heatmap (blue to red scale). Only genes displaying more than twofold changes are shown.
###end p 59
###begin p 60
###xml 54 55 54 55 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 84 87 84 87 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/&#8722;</sup>
###xml 90 93 90 93 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 111 114 111 114 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+</sup>
###xml 117 120 117 120 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+</sup>
###xml 263 264 263 264 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 265 266 265 266 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 376 377 376 377 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 385 386 385 386 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 396 397 396 397 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 121 125 <span type="species:ncbi:10090">mice</span>
###xml 224 228 <span type="species:ncbi:10090">mice</span>
###xml 295 299 <span type="species:ncbi:10090">mice</span>
###xml 420 425 <span type="species:ncbi:10090">mouse</span>
###xml 496 500 <span type="species:ncbi:10090">mice</span>
Functionality of islet grafts in diabetic recipients. A: Blood glucose levels in Id1+/-Id3-/- and wild-type Id1+/+Id3+/+ mice after streptozotocin injection. Shadowed area marks the limit of blood glucose values above which mice were considered frankly diabetic. B-D: Levels of blood glucose in mice rendered diabetic by streptozotocin and 1 week later transplanted with 500 (B), 200 (C), or 75 (D) wild-type islets per mouse. Values are means +/- SE of measurements from the indicated number of mice.
###end p 60
###begin p 61
###xml 147 151 <span type="species:ncbi:10090">mice</span>
Inflammation and angiogenesis-related genes differentially expressed in the grafts of bone marrow-reconstituted Id1/Id3-deficient versus wild-type mice
###end p 61
###begin p 62
###xml 105 109 <span type="species:ncbi:10090">mice</span>
###xml 265 269 <span type="species:ncbi:10090">mice</span>
Data are fold change. Genes exhibiting at least a twofold change between Id1/Id3-deficient and wild-type mice in the cell fractions of the indicated grafts are displayed. Values equal to 1 indicate no change of gene expression in Id1/Id3-deficient versus wild-type mice, whereas positive and negative values indicate upregulation and downregulation of specific genes, respectively. MMP, matrix metalloproteinase-7; SLAM, signaling lymphocytic activation molecule; SPARC, secreted protein, acidic, and rich in cysteine; TIMP, tissue inhibitor of metalloproteinase-1; TNF-alpha, tumor necrosis factor-alpha.
###end p 62

